Search Results - "YABUSHITA, Hiromitsu"

Refine Results
  1. 1

    Recurrent Serous Borderline Tumor After Fertility-Sparing Surgery Following Twin Pregnancy and Resumption of Menstruation by Morita, Noriko, Matsushita, Hiroshi, Yabushita, Hiromitsu, Wakatsuki, Akihiko

    Published in Curēus (Palo Alto, CA) (15-01-2024)
    “…Gynecologic malignancies sometimes affect women before menopause. Aggressive treatments, such as surgery, chemotherapy, and/or radiotherapy, often lead to…”
    Get full text
    Journal Article
  2. 2

    Clear-cell adenocarcinoma of the uterine cervix in a 17-year-old adolescent by Yabushita, Hiromitsu, Kanyama, Kouhei, Sekiya, Rinko, Noguchi, Mari, Wakatsuki, Akihiko

    Published in International journal of clinical oncology (01-12-2008)
    “…This report describes the case of the youngest Japanese person to be diagnosed with endocervical clearcell adenocarcinoma. In September 2005, a 17-year-old…”
    Get full text
    Journal Article
  3. 3

    Hyaluronan (HA) and Serum-Derived Hyaluronan-Associated Protein (SHAP)-HA Complex as Predictive Markers of Cervical Ripening in Premature Labor by Kishida, Tameko, Yabushita, Hiromitsu, Wakatsuki, Akihiko, Zhuo, Lisheng, Kimata, Koji

    Published in Connective Tissue Research (2008)
    “…The purpose of this study is to investigate whether serum hyaluronan (HA) and serum-derived HA-associated proteins (SHAP)-HA complex predict cervical ripening…”
    Get full text
    Journal Article
  4. 4

    Clinicopathological Role of Serum-Derived Hyaluronan-Associated Protein (SHAP)-Hyaluronan Complex in Endometrial Cancer by Yabushita, Hiromitsu, Iwasaki, Keita, Kanyama, Kouhei, Obayashi, Yukihiko, Zhuo, Lisheng, Itano, Naoki, Kimata, Koji, Wakatsuki, Akihiko

    Published in Obstetrics and Gynecology International (01-01-2011)
    “…The role of hyaluronan (HA), serum-derived HA-associated protein (SHAP)-HA complex and hyaluronan synthase (HAS) in endometrial carcinomas was investigated…”
    Get full text
    Journal Article
  5. 5

    A case of Ifosfamide-induced dysuria which could be avoided by changing the regimen of mesna by Yamamoto, Yoshihiro, Tsukiyama, Ikuto, Nii, Shota, Harada, Ryusuke, Watanabe, Kazushi, Yabushita, Hiromitsu, Wakatsuki, Akihiko, Saito, Hiroko, Hasegawa, Takaaki

    Published in Gan to kagaku ryoho (01-03-2013)
    “…A 39-year-old woman with advanced and recurrent cervical carcinoma received chemotherapy with IFM+CDDP(IFM 5, 000mg/m2 by intravenous infusion for 24 hours and…”
    Get more information
    Journal Article
  6. 6

    Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin by Yamamoto, Yoshihiro, Watanabe, Kazushi, Tsukiyama, Ikuto, Matsushita, Hiroshi, Yabushita, Hiromitsu, Matsuura, Katsuhiko, Wakatsuki, Akihiko

    Published in Anticancer research (01-04-2015)
    “…The present study aimed to assess the efficacy of 15 mEq magnesium supplied as part of a prehydration regimen in preventing cisplatin-induced nephrotoxicity in…”
    Get full text
    Journal Article
  7. 7

    Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer by IWASAKI, KEITA, YABUSHITA, HIROMITSU, UENO, TAIKI, WAKATSUKI, AKIHIKO

    Published in Oncology letters (01-10-2015)
    “…The aim of the present study was to determine whether the expression of hypoxia-inducible factor-1α (HIF-1α), carbonic anhydrase-IX (CA-IX), glucose…”
    Get full text
    Journal Article
  8. 8

    Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy by Yamamoto, Yoshihiro, Watanabe, Kazushi, Tsukiyama, Ikuto, Yabushita, Hiromitsu, Matsuura, Katsuhiko, Wakatsuki, Akihiko

    Published in Anticancer research (01-04-2016)
    “…We aimed to assess whether the efficacy of pre-hydration with 15 mEq magnesium prevents cisplatin-induced nephrotoxicity in cisplatin regimens (dosage: 50…”
    Get full text
    Journal Article
  9. 9

    Prediction of cell kill kinetics of anticancer agents using the collagen gel droplet embedded-culture drug sensitivity test by Mori, Takeshi, Ohnishi, Masafumi, Komiyama, Megumi, Tsutsui, Arisa, Yabushita, Hiromitsu, Okada, Hiroshi

    Published in Oncology reports (01-03-2002)
    “…A vital component of chemotherapy is selecting effective anticancer agents for the patient and determining an appropriate dose and administration regimen…”
    Get more information
    Journal Article
  10. 10

    Abstract 4738: Clinicopathological roles of adiponectin receptor and leptin receptor in endometrial carcinoma by Yabushita, Hiromitsu, Iwasaki, Keita, Ueno, Taiki, Wakatsuki, Akihiko

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Objectives: To clarify the roles of adiponectin receptor (AdipoR) and leptin receptor (ObR) in endometrial carcinoma, expressions of AdipoR-1 and -2 and ObR in…”
    Get full text
    Journal Article
  11. 11

    Abstract 4737: Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX and glucose transporter-1 in cervical cancer by Iwasaki, Keita, Yabushita, Hiromitsu, Ueno, Taiki, Wakatsuki, Akihiko

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Objectives: Hypoxia can drive the tumor toward a more aggressive malignant phenotype through genomic and proteomic changes. Hypoxia-inducible factor-1α…”
    Get full text
    Journal Article
  12. 12

    The Association of Transforming Growth Factor-β1 with Myometrial Invasion of Endometrial Carcinomas through Effects on Matrix Metalloproteinase by Yabushita, Hiromitsu, Narumiya, Hisao, Hiratake, Kanji, Yamada, Hidefumi, Shimazu, Mitsuma, Sawaguchi, Keizo, Noguchi, Masayoshi, Nakanishi, Masami

    “…Objective: The association of transforming growth factor‐β1 (TGF‐β1) with a matrix metalloproteinase (MMP) and a tissue inhibitor of metalloproteinase (TIMP),…”
    Get full text
    Journal Article
  13. 13

    Effects of Electrochemotherapy on CaSki Cells Derived from a Cervical Squamous Cell Carcinoma by Yabushita, Hiromitsu, Yoshikawa, Kazuhiro, Hirata, Masato, Furuya, Hiroshi, Hojyoh, Tatsuhiko, Fukatsu, Hidetoshi, Noguchi, Masayoshi, Nakanishi, Masami

    Published in Gynecologic oncology (01-05-1997)
    “…Electrochemotherapy is a new approach to the treatment of tumors that takes advantage of the permeabilization of the cell membranes by electric pulses to…”
    Get full text
    Journal Article
  14. 14

    Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma by YABUSHITA, HIROMITSU, IWASAKI, KEITA, OBAYASHI, YUKIHIKO, WAKATSUKI, AKIHIKO

    Published in Oncology letters (01-04-2014)
    “…To clarify the roles of adiponectin receptor (AdipoR) and leptin receptor (ObR) in endometrial carcinoma, the expression of AdipoR-1 and -2 and ObR in…”
    Get full text
    Journal Article
  15. 15

    Emergence of an Irreversible Differentiated Subclone from the Poorly Differentiated Ovarian Adenocarcinoma Cell Line AMOC-2 Treated with Sodium Butyrate by Yabushita, Hiromitsu, Noguchi, Masayoshi, Nakanishi, Masami

    “…Objective: To cast light on the capacity of an ovarian adenocarcinoma to undergo irreversible cellular differentiation, we established clonal cell lines from…”
    Get full text
    Journal Article
  16. 16

    Occult Lymph Node Metastases Detected by Cytokeratin Immunohistochemistry Predict Recurrence in Node-Negative Endometrial Cancer by Yabushita, Hiromitsu, Shimazu, Mitsuma, Yamada, Hidefumi, Sawaguchi, Keizo, Noguchi, Masayoshi, Nakanishi, Masami, Kawai, Michiyasu

    Published in Gynecologic oncology (01-02-2001)
    “…Objective. Even after curative resection of early endometrial cancer, some patients die as a result of recurrence. We believe that these patients likely had…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer by OBAYASHI, Yukihiko, YABUSHITA, Hiromitsu, KANYAMA, Kouhei, NOGUCHI, Mari, LISHENG ZHUO, KIMATA, Koji, WAKATSUKI, Akihiko

    Published in Oncology reports (01-05-2008)
    “…The objective of this study was to determine if the level of serum hyaluronan (HA), serum-derived HA-associated protein (SHAP)-HA complex, and urinary trypsin…”
    Get full text
    Journal Article
  18. 18

    Hyaluronan synthase expression in ovarian cancer by Yabushita, Hiromitsu, Noguchi, Mari, Kishida, Tameko, Fusano, Kanako, Noguchi, Yasuyuki, Itano, Naoki, Kimata, Koji, Noguchi, Masayoshi

    Published in Oncology reports (01-10-2004)
    “…To determine if the immunohistochemical expression of hyaluronan synthase (HAS) correlates with the clinicopathological manifestations or clinical outcomes of…”
    Get more information
    Journal Article
  19. 19

    Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer by Yabushita, Hiromitsu, Shimazu, Mitsuma, Noguchi, Mari, Kishida, Tameko, Narumiya, Hisao, Sawaguchi, Keizo, Noguchi, Masayoshi

    Published in Oncology reports (01-01-2003)
    “…The role of vascular endothelial growth factor (VEGF) during peritoneal dissemination of ovarian carcinoma and the association with tumor microvessel density…”
    Get more information
    Journal Article
  20. 20

    Recurrent Serous Borderline Tumor After Fertility-Sparing Surgery Following Twin Pregnancy and Resumption of Menstruation by Morita, Noriko, Matsushita, Hiroshi, Yabushita, Hiromitsu, Wakatsuki, Akihiko

    Published in Cureus (01-01-2024)
    “…Gynecologic malignancies sometimes affect women before menopause. Aggressive treatments, such as surgery, chemotherapy, and/or radiotherapy, often lead to…”
    Get full text
    Report